These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6981747)

  • 1. Possible link between changes in plasma 24,25-dihydroxyvitamin D and healing of bone resorption in dialysis osteodystrophy.
    Lambrey G; N'Guyen TM; Garabedian M; Sebert JL; de Fremont JF; Marie P; Caillens C; Gueris J; Meunier P; Balsan S; Fournier A
    Metab Bone Dis Relat Res; 1982; 4(1):25-30. PubMed ID: 6981747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3.
    van Diemen-Steenvoorde R; Donckerwolcke RA; Bosch R; Visser WJ; Raymakers JA; Duursma SA
    Clin Nephrol; 1985 Dec; 24(6):292-9. PubMed ID: 3878249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
    Pettifor JM
    Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis.
    Main J; Velasco N; Catto GR; Fraser RA; Edward N; Adami S; O'Riordan JL
    Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients.
    Mortensen BM; Aarseth HP; Ganss R; Haug E; Gautvik KM; Gordeladze JO
    Bone; 1993; 14(2):125-31. PubMed ID: 8334029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.
    Kruse K
    J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.
    Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T
    Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients.
    Fanti P; Smith AJ; Price PA; Reitz RE; Malluche HH
    J Clin Endocrinol Metab; 1986 May; 62(5):869-73. PubMed ID: 3485651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma 1,25 and 24,25-dihydroxyvitamin D after renal transplantation in children.
    Garabedian M; Silve C; Levy-Bentolila D; Bourdeau A; Ulmann A; Nguyen TM; Lieberherr M; Broyer M; Balsan S
    Kidney Int; 1981 Sep; 20(3):403-10. PubMed ID: 7029120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.
    Jablonski G; Mortensen BM; Klem KH; Mosekilde L; Danielsen CC; Gordeladze JO
    Calcif Tissue Int; 1995 Nov; 57(5):385-91. PubMed ID: 8564802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P; Zingraff J; Gueris J; Jungers P; Marie P; Pechet M; Rasmussen H
    Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal osteodystrophy (2): its treatment in renal insufficiency before dialysis].
    Hottelart C; Bako G; Oprisiu R; Georgita A; Presne C; Sarraj A; Morinière P; el Esper N; Fournier A
    Nephrologie; 2000; 21(6):275-82. PubMed ID: 11117106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sunlight exposure on circulating 1,25-dihydroxyvitamin D in hemodialyzed patients and of exogenous parathyroid hormone in anephric patients.
    Sørensen OH; Lund B; Thode JD; Storm TL; Lund B; Brahm M; Friedberg M; Holmegaard SN
    Acta Med Scand; 1986; 219(2):215-9. PubMed ID: 3485891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.